David Loew
Directeur Général chez IPSEN
Fortune : 61 001 $ au 30/04/2024
Actualités sur David Loew
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANOFI | Health Technology |
| IPSEN | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| GAVI Alliance | Miscellaneous |
| European Federation of Pharmaceutical Industries & Assoc | Commercial Services |
| G5 Santé |
Formation de David Loew
| University of St. Gallen | Masters Business Admin |
- Bourse
- Insiders
- David Loew
- Actualités
